Safety and Efficacy of the Combo Bio-Engineered Stent in an All-Comer PCI Cohort: Results from the MASCOT Post-Marketing Registry

被引：0
|
作者：
Colombo, Antonio [1 ]
Rowland, Stephen [2 ]
Chandrasekhar, Jaya [3 ]
Ong, Tiong Kiam [4 ]
Lee, Michael [5 ]
Snyder, Clayton [3 ]
Aquino, Melissa [6 ]
Morrell, Debbie [7 ]
Elmore, Francesca [7 ]
Mehran, Roxana [8 ]
机构：
[1] Ist Sci San Raffaele, Milan, Italy
[2] OrbusNeich Med, Ft Lauderdale, FL USA
[3] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
[4] Sarawak Gen Hosp, Ctr Heart, Kota Samarahan, Malaysia
[5] Queen Elizabeth Hosp, Dept Med, Kowloon, Hong Kong, Peoples R China
[6] Mt Sinai Med Ctr, New York, NY 10029 USA
[7] OrbusNeich, Ft Lauderdale, FL USA
[8] Mt Sinai Hosp, Zena & Michael A Wiener Cardiovasc Inst, New York, NY 10029 USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2017年 / 70卷 / 18期
关键词：
D O I：
10.1016/j.jacc.2017.09.151
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
TCT-94
引用
收藏
页码：B41 / B41
页数：1
相关论文
共 29 条
  • [21] Assessment of Sirolimus-Eluting Coronary Stent Implantation With Aspirin Plus Low Dose Ticlopidine Administration - One Year Results From CYPHER Stent Japan Post-Marketing Surveillance Registry (J-PMS)
    Ikari, Yuji
    Kotani, Junichi
    Kozuma, Ken
    Kyo, Eishou
    Nakamura, Masato
    Yokoi, Hiroyoshi
    CIRCULATION JOURNAL, 2009, 73 (06) : 1038 - 1044
  • [22] Efficacy and safety of saxagliptin monotherapy or added to metformin in Chinese patients with type 2 diabetes mellitus: results from the 24-week, post-marketing SUNSHINE study
    Gu, Weiqiong
    Liang, Li.
    Wang, Shengxiang
    Wang, Yunzhi
    Wu, Yanxiang
    Tian, Jian
    Yang, Gangyi
    Piao, Chunli
    Li, Yuzhong
    Yin, Jianmei
    Xin, Xiaoping
    Tan, Xingrong
    Ning, Guang
    Wang, Weiqing
    JOURNAL OF DIABETES, 2016, 8 (06) : 809 - 815
  • [23] Safety of the CYPHER® sirolimus-eluting stent under an aspirin and ticlopidine regimen in routine clinical practice:: Interim results from the Japanese post-marketing surveillance registry mandated 8-month angiographic follow-up
    Ikari, Yuji
    Kotani, Jun-ichi
    Kyo, Eisyo
    Nakamura, Masato
    Yokoi, Hiroyoshi
    CIRCULATION, 2006, 114 (18) : 592 - 593
  • [24] Safety profiles and efficacy of infliximab therapy in Japanese patients with plaque psoriasis with or without psoriatic arthritis, pustular psoriasis or psoriatic erythroderma: Results from the prospective post-marketing surveillance
    Torii, Hideshi
    Terui, Tadashi
    Matsukawa, Miyuki
    Takesaki, Kazumi
    Ohtsuki, Mamitaro
    Nakagawa, Hidemi
    JOURNAL OF DERMATOLOGY, 2016, 43 (07): : 767 - 778
  • [25] Safety and Efficacy of Sorafenib in Japanese Patients with Renal Cell Carcinoma under Daily Medical Practice: Result from the Post-Marketing All-Patient Surveillance with >3200 Cases
    Adachi, M.
    Okayama, Y.
    Kubo, T.
    Akaza, H.
    Yamanaka, S.
    UROLOGY, 2012, 80 (03) : S23 - S24
  • [26] Interim safety results from the all cases post-marketing study (PMS) of sunitinib in 1,027 Japanese patients with renal cell carcinoma (RCC) or gastrointestinal stromal tumor (GIST).
    Agata, N.
    Ueno, N.
    Houzawa, H.
    Ueda, E.
    Komatsu, Y.
    Nishida, T.
    Naito, S.
    Akaza, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [27] A large-scale prospective registration study of the safety and efficacy of sorafenib tosylate in unresectable or metastatic renal cell carcinoma in Japan: results of over 3200 consecutive cases in post-marketing all-patient surveillance
    Akaza, Hideyuki
    Oya, Mototsugu
    Iijima, Masafumi
    Hyodo, Ichinosuke
    Gemma, Akihiko
    Itoh, Hiroshi
    Adachi, Masatoshi
    Okayama, Yutaka
    Sunaya, Toshiyuki
    Inuyama, Lyo
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2015, 45 (10) : 953 - 962
  • [28] Venovo venous stent for treatment of non-thrombotic or post-thrombotic iliac vein lesions - long-term efficacy and safety results from the Arnsberg venous registry
    Lichtenberg, Michael K. W.
    Stahlhoff, Wilhelm F.
    Stahlhoff, Stefan
    Oezkapi, Ahmet
    Breuckmann, Frank
    de Graaf, Rick
    VASA-EUROPEAN JOURNAL OF VASCULAR MEDICINE, 2021, 50 (01) : 52 - 58
  • [29] Efficacy and Safety of Burosumab in Adult Chinese Patients with Tumor-induced Osteomalacia (TIO): Analysis from an Open-Label, Multi-center, Single-cohort, Post-marketing Phase IV Study
    Xia, Weibo
    Zhang, Zhenlin
    Lu, Chunyan
    Yamaguchi, Saaya
    Bai, Man
    Yi, Junming
    Onuma, Hiroki
    JOURNAL OF BONE AND MINERAL RESEARCH, 2024, 39 : 105 - 106
123